Key facts
- This page summarizes Daniel S. Jonas's Form 4 filing for CONMED Corp (CNMD).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 15:45.
Daniel S. Jonas - 01 Mar 2023 Form 4 Insider Report for CONMED Corp (CNMD)
- Reporting relationship
- Special Counsel & Corp Secy
- Issuer ticker
- CNMD
- Reported as of
- 01 Mar 2023
- Net transaction value
- -$353,294
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 15:45:39 UTC
- Prior SEC filing
- 05 Jun 2023
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- Daniel S. Jonas
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel S. Jonas filed Form 4 for CONMED Corp (CNMD) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 05 Jun 2023.
- Current net transaction value: -$353,294.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,500
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 14,784
- Date
- 01 Mar 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Tax liability
- Transaction value
- $70,774
- Shares
- -736
- Change %
- -5%
- Price
- $96.16
- Shares after
- 14,048
- Date
- 01 Mar 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $323,784
- Shares
- +5,400
- Change %
- +38%
- Price
- $59.96
- Shares after
- 19,448
- Date
- 02 Mar 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $519,723
- Shares
- -5,400
- Change %
- -28%
- Price
- $96.24
- Shares after
- 14,048
- Date
- 02 Mar 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $393,800
- Shares
- +5,000
- Change %
- +36%
- Price
- $78.76
- Shares after
- 19,048
- Date
- 02 Mar 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $480,381
- Shares
- -5,000
- Change %
- -26%
- Price
- $96.08
- Shares after
- 14,048
- Date
- 02 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Rsus (restricted Stock Units)
Options Exercise
- Transaction value
- $0
- Shares
- -2,500
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $0.000000
- Footnotes
- F2
CNMD
transaction
Derivative
Rsus (restricted Stock Units)
Award
- Transaction value
- $0
- Shares
- +3,000
- Change %
- Price
- $0.000000
- Shares after
- 3,000
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $0.000000
- Footnotes
- F3
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -5,400
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,400
- Exercise price
- $59.96
- Footnotes
- F4
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 5,000
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $78.76
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
Footnote F3
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
Footnote F4
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Footnote F5
The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period